iLAC is a genuinely unique entity devoted to fertile promotion of “precision medicine” (meticulously individualized medical procedures), which facilitates selection of optimum treatments, medications and other advances tailored to the needs of specific patients. With that vision in mind, iLAC provides high-throughput genome analysis, expression analysis and genome structure analysis applied to multiple specimens. Likewise mobilized are proteome, metabolomic and other omics analysis networks effective in formulating pathological evaluation systems on the strength of multidimensional markers.
Employing its high value-added, extensive and detailed databases, the laboratory contributes to the discovery of new therapeutic targets, fulfillment of healthy longevity against the backdrop of today’s aging society, and feasible curbs on healthcare costs.